Oratech Pharmaceuticals

Company Overview

Snapshot

Founded in March 2026, Oratech Pharmaceuticals operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on advancing and commercializing oral drug delivery assets.

Business overview

Oratech Pharmaceuticals is a pharmaceutical venture specializing in oral drug delivery technologies. The company's core product includes an oral insulin capsule program, leveraging advanced oral protein delivery technology and strategic manufacturing partnerships. Oratech Pharmaceuticals is focused on progressing the clinical development and regulatory pathways for oral insulin, with plans to expand its oral delivery platform to encompass additional therapeutics within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drug Delivery.

Company Intelligence Q&A

What is Oratech Pharmaceuticals' primary focus?

Oratech Pharmaceuticals is focused on advancing and commercializing oral drug delivery assets, including an oral insulin capsule program, leveraging oral protein delivery technology and manufacturing partnerships.

When was Oratech Pharmaceuticals founded?

Oratech Pharmaceuticals was founded in March 2026.

What is Oratech Pharmaceuticals' funding stage?

Oratech Pharmaceuticals is currently in the Pre-Funding stage, indicating it is seeking initial investment to develop its oral drug delivery assets.

What is Oratech Pharmaceuticals' primary sector?

Oratech Pharmaceuticals operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drug Delivery.

What is the current product stage for Oratech Pharmaceuticals?

Oratech Pharmaceuticals' products are currently in the Clinical Trial stage, actively progressing through human studies to evaluate safety and efficacy.